,
3 tweets,
2 min read
Read on Twitter
There’s a provision in the new NAFTA that would add two years of IP protection for certain medicines in Canada, and forbid the US from setting the number of protected years as low as Dems want. It’s one of the key obstacles to the House approving the deal: thestar.com/content/thesta…
A Democratic pollster found that discussing this provision is the “single most powerful” argument against the new NAFTA with white working-class Obama-Trump voters, who see it as capitulation to Big Pharma, @ThePlumLineGS reports: washingtonpost.com/opinions/2019/…
It was always obviously a revised NAFTA, but at first everyone official, even the Canadian government, insisted it was the USMCA, so that's what we had to call it...but then the Canadians were like ok who cares it's "new NAFTA," liberating us reporters.
